【AEA 2020 Alumni】
Biogenes Technologies Sdn Bhd (Biogenes) is a Malaysian-based startup company founded in 2015. Biogenes developed aptamer-based biosensor technologies and solutions in rapid test devices in molecular diagnostics for disease testing. Biogenes’ rapid test devices are designed to serve customers from various sectors ranging from healthcare, animal breeding, aquaculture, agriculture and environmental monitoring.

In the wave of the current global pandemic, Biogenes has developed a rapid antigen test kit called COVIDSENSETM with real-time digital communication capabilities to provide location and data to the users and medical stakeholders. This test kit is able to conduct fast and efficient testing utilizing the proprietary aptamer-based technologies developed by Biogenes to detect the presence of COVID-19 Virus (SARS-COV-2) with both high selectivity and sensitivity. Biogenes unique deep tech platform allows Biogenes to add more infectious disease including MERS, SARS, TB, and other communicable and non-communicable diseases in human, animals and plants. Biogenes aims to build a library of tests which includes diseases in This will enable Biogenes to overcome the current pandemic while laying the ground work for future growth into the diagnostic sector. Biogenes wants to build simple, easily scalable and user-friendly tests for now and the future. This will be in line with Biogenes’ tagline ‘Diagnostics Simplified’